JSAM
CGON icon

J. Safra Asset Management’s CG Oncology CGON Stock Holding History

J. Safra Asset Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.9K Sell
238
-38
-14% -$2.48K ﹤0.01% 342
2026
Q1 		$18.7K Buy
276
+204
+283% +$11.6K ﹤0.01% 312
2025
Q4 		$2.99K Buy
72
+61
+555% +$2.52K ﹤0.01% 499
2025
Q3 		$443 Hold
11
– – ﹤0.01% 464
2025
Q2 		$286 Buy
+11
New +$265 ﹤0.01% 365

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

J. Safra Asset Management's CGON Position: Q2 2026 in Review

J. Safra Asset Management reduced its CG Oncology (CGON) stake by 14% in Q2 2026, selling an estimated $2.48K and leaving 238 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #342.

J. Safra Asset Management first reported a position in CGON in Q2 2025 and has held it in 5 quarters since. The position peaked at $18.7K in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • J. Safra Asset Management held 238 shares of CG Oncology worth $16.9K as of Q2 2026.
  • J. Safra Asset Management sold 38 CG Oncology shares in Q2 2026, an estimated $2.48K.
  • CG Oncology made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #342 holding.
  • J. Safra Asset Management first reported a position in CG Oncology in Q2 2025 and has held it in 5 quarters since.
  • J. Safra Asset Management's CG Oncology position peaked at $18.7K in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.